Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON39523Phase 3Active, not recruiting
Phase 3, randomised, open-label trial of misoprostol (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Composite complications of uterine hyperstimulation and Instrumental delivery rate. Started Jul 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON39523.